{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:03:23Z","timestamp":1782446603498,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","award":["PID2020-113430RB-I00"],"award-info":[{"award-number":["PID2020-113430RB-I00"]}],"id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","award":["PID2024-158925OB-I00"],"award-info":[{"award-number":["PID2024-158925OB-I00"]}],"id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nbd.2025.107131","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:19:37Z","timestamp":1759540777000},"page":"107131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cannabidiol releases CB1R from A2AR repression in ischemic stroke"],"prefix":"10.1016","volume":"216","author":[{"given":"Iu","family":"Ra\u00efch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Lillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Biel","family":"Rebassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rivas-Santisteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Santandreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Reyes-Resina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez-Orgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107131_bb0005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid Cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2025.107131_bb0010","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s12035-018-1456-3","article-title":"Adenosine A2A-cannabinoid CB1 receptor Heteromers in the Hippocampus: Cannabidiol blunts \u03949-tetrahydrocannabinol-induced cognitive impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107131_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316728","article-title":"Neuroprotection and beyond: the central role of CB1 and CB2 receptors in stroke recovery","volume":"24","author":"Bietar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107131_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.18869\/nirp.bcn.8.2.139","article-title":"Correlation between Cannabidiol-induced reduction of infarct volume and inflammatory factors expression in ischemic stroke model","volume":"8","author":"Bigdeli","year":"2017","journal-title":"Basic Clin. Neurosci. J."},{"key":"10.1016\/j.nbd.2025.107131_bb0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0028-3908(97)00139-1","article-title":"Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists","volume":"36","author":"Bona","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.107131_bb0030","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.npp.1301375","article-title":"Striatal adenosine A2A and cannabinoid CB1 receptors form functional Heteromeric complexes that mediate the motor effects of cannabinoids","volume":"32","author":"Carriba","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2025.107131_bb0035","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.006","article-title":"Expression of the endocannabinoid receptor 1 in human stroke: an Autoptic study","volume":"25","author":"Caruso","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.nbd.2025.107131_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2016.12.017","article-title":"Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke","volume":"116","author":"Cepri\u00e1n","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.107131_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(99)00299-3","article-title":"Heparin and Oral anticoagulants in the treatment of brain ischemia","volume":"173","author":"Chaves","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107131_bb0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/jnc.13421","article-title":"Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors","volume":"136","author":"Chiodi","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107131_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.31887\/DCNS.2020.22.3\/mcrocq","article-title":"History of Cannabis and the endocannabinoid system","volume":"22","author":"Crocq","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.nbd.2025.107131_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuropharm.2008.01.005","article-title":"Mechanisms of ischemic brain damage","volume":"55","author":"Doyle","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.107131_bb0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and National Burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107131_bb0070","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/brainsci3031043","article-title":"Cannabinoids: well-suited candidates for the treatment of perinatal brain injury","volume":"3","author":"Fern\u00e1ndez-L\u00f3pez","year":"2013","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2025.107131_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this Phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107131_bb0080","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jnc.13520","article-title":"Dissecting striatal adenosine-cannabinoid receptor interactions. New clues from rats over-expressing adenosine A2A receptors","volume":"136","author":"Ferr\u00e9","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107131_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nchembio0309-131","article-title":"Building a new conceptual framework for receptor Heteromers","volume":"5","author":"Ferr\u00e9","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2025.107131_bb0090","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/glia.23694","article-title":"Potentiation of cannabinoid signaling in microglia by adenosine a 2A receptor antagonists","volume":"67","author":"Franco","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2025.107131_bb0095","series-title":"Calcium-Binding Proteins and RAGE: From Structural Basics to Clinical Applications","first-page":"147","article-title":"Super-resolution microscopy of the neuronal calcium-binding proteins Calneuron-1 and Caldendrin","author":"Hradsky","year":"2013"},{"key":"10.1016\/j.nbd.2025.107131_bb0100","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1523\/JNEUROSCI.5073-13.2014","article-title":"Differential effects of presynaptic versus postsynaptic adenosine a 2A receptor blockade on \u0394 9 -tetrahydrocannabinol (THC) self-administration in squirrel monkeys","volume":"34","author":"Justinov\u00e1","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107131_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00359","article-title":"Barrier mechanisms in neonatal stroke","volume":"8","author":"Kratzer","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.107131_bb0110","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107131_bb0115","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.3390\/ijms23179695","article-title":"Regulation of expression of cannabinoid CB2 and serotonin 5HT1A receptor complexes by cannabinoids in animal models of hypoxia and in oxygen\/glucose-deprived neurons","volume":"23","author":"Lillo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107131_bb0120","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1021\/acs.jcim.3c01054","article-title":"The Leu\/Val 6.51 side chain of cannabinoid receptors regulates the binding mode of the alkyl chain of \u0394 9 -tetrahydrocannabinol","volume":"63","author":"Llinas del Torrent","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.nbd.2025.107131_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.584533","article-title":"Cannabidiol for the treatment of neonatal hypoxic-ischemic brain injury","volume":"11","author":"Mart\u00ednez-Orgado","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107131_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for Cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107131_bb0135","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/npp.2017.12","article-title":"Singular location and signaling profile of adenosine A2A-cannabinoid CB1 receptor Heteromers in the dorsal striatum","volume":"43","author":"Moreno","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2025.107131_bb0140","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1100\/tsw.2008.136","article-title":"Detection of heteromers formed by cannabinoid CB 1, dopamine D 2, and adenosine A 2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer","volume":"8","author":"Navarro","year":"2008","journal-title":"Sci. World J."},{"key":"10.1016\/j.nbd.2025.107131_bb0145","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1523\/JNEUROSCI.4364-14.2015","article-title":"Orexin\u2013Corticotropin-releasing factor receptor Heteromers in the ventral tegmental area as targets for cocaine","volume":"35","author":"Navarro","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107131_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00422","article-title":"Vascular dysfunction in a transgenic model of Alzheimer\u2019s disease: effects of CB1R and CB2R cannabinoid agonists","volume":"10","author":"Navarro-Dorado","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.107131_bb0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpeds.2017.08.031","article-title":"Neuroprotective strategies in neonatal brain injury","volume":"192","author":"Parikh","year":"2018","journal-title":"J. Pediatr."},{"key":"10.1016\/j.nbd.2025.107131_bb0160","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia\u2013ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.107131_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417500","article-title":"Cannabidiol at Nanomolar concentrations negatively affects signaling through the adenosine A2A receptor","volume":"24","author":"Ra\u00efch","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107131_bb0170","first-page":"1","article-title":"Cannabidiol negatively modulates adenosine a 2A receptor functioning in living cells","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2023","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.nbd.2025.107131_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.taap.2019.02.011","article-title":"DMH-CBD, a Cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-KB activity dependent on A2A receptor","volume":"368","author":"Silva","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107131_bb0180","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.3390\/molecules26175354","article-title":"Contribution of the adenosine 2A receptor to behavioral effects of tetrahydrocannabinol, Cannabidiol and PECS-101","volume":"26","author":"Stollenwerk","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.nbd.2025.107131_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/can.2020.0159","article-title":"protective effects of cannabidivarin and cannabigerol on cells of the blood\u2013brain barrier under ischemic conditions","volume":"6","author":"Stone","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.nbd.2025.107131_bb0190","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0140-6736(98)90086-1","article-title":"Epidemiology of stroke","volume":"352","author":"Warlow","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107131_bb0195","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/jcbfm.2013.117","article-title":"Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet","volume":"33","author":"Yang","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:25:00Z","timestamp":1762028700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125003481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"alternative-id":["S0969996125003481"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107131","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol releases CB1R from A2AR repression in ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107131"}}